4.6 Review

Organoid and Spheroid Tumor Models: Techniques and Applications

期刊

CANCERS
卷 13, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13040874

关键词

organoids; spheroids; air– liquid interface; personalized medicine; drug screening; tumor modeling; organoid biobanks; immunotherapy; microfluidics; organoids-on-chip

类别

资金

  1. Intramural Research Program of the United States NIH, NIDCD
  2. NIH
  3. Doris Duke Charitable Foundation (DDCF) [2014194]
  4. American Association for Dental Research
  5. Colgate-Palmolive Company
  6. Genentech
  7. Elsevier

向作者/读者索取更多资源

3D cell culture models like organoids and spheroids have unique advantages and applications, with organoids resembling the original tissue and being suitable for personalized medicine. Organoid-on-chip models combine organoid methods with micro-chip technology to simulate dynamic microenvironments.
Simple Summary Cell cultures can be carried out in three dimensions (3D). Organoids and spheroids are different 3D cell culture models that can be cultured with different techniques. These 3D cell culture units established from a patient tumor have several similarities to the original tumor tissue and possess several advantages in conducting basic and clinical cancer research. Organoids prepared from a patient tissue can be preserved in a living biobank. Testing chemo-, radio- and immuno-therapies on these organoids has the potential to predict the patient responses and these models have incredible promise for personalized medicine. This review presents different organoid models, the techniques to prepare them and recent advances in their applications. Techniques to develop three-dimensional cell culture models are rapidly expanding to bridge the gap between conventional cell culture and animal models. Organoid and spheroid cultures have distinct and overlapping purposes and differ in cellular sources and protocol for establishment. Spheroids are of lower complexity structurally but are simple and popular models for drug screening. Organoids histologically and genetically resemble the original tumor from which they were derived. Ease of generation, ability for long-term culture and cryopreservation make organoids suitable for a wide range of applications. Organoids-on-chip models combine organoid methods with powerful designing and fabrication of micro-chip technology. Organoid-chip models can emulate the dynamic microenvironment of tumor pathophysiology as well as tissue-tissue interactions. In this review, we outline different tumor spheroid and organoid models and techniques to establish them. We also discuss the recent advances and applications of tumor organoids with an emphasis on tumor modeling, drug screening, personalized medicine and immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Rapid Decay of the Native Intermediate in the Metallooxidase Fet3p Enables Controlled FeII Oxidation for Efficient Metabolism

Stephen M. Jones, David E. Heppner, Kenny Vu, Daniel J. Kosman, Edward Solomon

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Clinical Neurology

Postoperative Pain Management and Perceived Patient Outcomes following Endoscopic Pituitary Surgery

Austin T. K. Hoke, Madison Malfitano, Adam M. Zanation, Charles S. Ebert, Brent A. Senior, Adam J. Kimple, Brian D. Thorp

Summary: This study investigates the prescribing and use of opioid analgesics following endoscopic pituitary surgery, and finds a wide variation in prescribing practices among providers and a lack of standardized protocols.

JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2022)

Article Oncology

Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells

Austin T. K. Hoke, Michelle R. Padget, Kellsye P. Fabian, Anjali Nandal, Gary L. Gallia, Marijo Bilusic, Patrick Soon-Shiong, James W. Hodge, Nyall R. London Jr

Summary: Research has shown that using anti-PD-L1 and anti-EGFR antibodies can enhance NK cell lysis of chordoma cells, and NK cell toxicity against chordoma cells is increased after treatment with IL15 superagonist complex.

CANCER RESEARCH COMMUNICATIONS (2021)

暂无数据